Sign in
4

Changes in Ownership

Petros Pharmaceuticals, Inc. Filed Acc 0001104659-23-053227

Director acquired 6,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bradley Greg Director 2023-04-26 Option exercise +6,050 8,314 D
Derivatives
Bradley Greg Director 2023-04-26 Option exercise · Restricted Stock Units −6,050 0 D
Loading xslF345X04/tm2313909-4_4seq1.xml…